// App-Quantinova.ai

2397 : Expression of a Dysfunctional Activation Induced Cytidine Deaminase Is Correlated with Disease Progression in Splenic Marginal Zone Lymphoma.

Researchers

Presenter

  • Laurent Jallades

Principal Investigators

  • Alexandra Traverse-Glehen

  • Francoise Berger

  • Aurelie Verney

  • Gilles Salles

  • Thomas Wenner

Medical Centers

  • Hematologie UMR CNRS, Centre Hospitalier Universitaire Lyon-Sud, Lyon, France

  • Department of Pathology and Hematology, Hospices Civils de Lyon, University Lyon 1, Lyon, France

  • LBMC CNRS/ENS Lyon/UCBL/HCL, Oullins, France

  • Hospices Civils de Lyon, Universite Lyon-1, Lyon, France

  • LBMC CNRS/ENS Lyon/UCBL/HCL/Synergie Lyon Cancer, Oullins, France

  • Hospices Civils De Lyon, Pierre Benite, France

Locations

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Mucosa-associated lymphoid tissue lymphoma

  • B cell lymphomas

  • Lymphomas

Biomarkers

  • Scavenger Receptor Class A Member 3

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim